Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Elsevier Science full text link Elsevier Science Free PMC article
Full text links

Actions

.2008 Mar 28;283(13):8250-7.
doi: 10.1074/jbc.M705933200. Epub 2008 Jan 21.

Functional interactions of alcohol-sensitive sites in the N-methyl-D-aspartate receptor M3 and M4 domains

Affiliations

Functional interactions of alcohol-sensitive sites in the N-methyl-D-aspartate receptor M3 and M4 domains

Hong Ren et al. J Biol Chem..

Abstract

The N-methyl-D-aspartate receptor is an important mediator of the behavioral effects of ethanol in the central nervous system. Previous studies have demonstrated sites in the third and fourth membrane-associated (M) domains of the N-methyl-D-aspartate receptor NR2A subunit that influence alcohol sensitivity and ion channel gating. We investigated whether two of these sites, Phe-637 in M3 and Met-823 in M4, interactively regulate the ethanol sensitivity of the receptor by testing dual substitution mutants at these positions. A majority of the mutations decreased steady-state glutamate EC(50) values and maximal steady-state to peak current ratios (I(ss)/I(p)), whereas only two mutations altered peak glutamate EC(50) values. Steady-state glutamate EC(50) values were correlated with maximal glutamate I(ss)/I(p) values, suggesting that changes in glutamate potency were attributable to changes in desensitization. In addition, there was a significant interaction between the substituents at positions 637 and 823 with respect to glutamate potency and desensitization. IC(50) values for ethanol among the mutants varied over the approximate range 100-325 mm. The sites in M3 and M4 significantly interacted in regulating ethanol sensitivity, although this was apparently dependent upon the presence of methionine in position 823. Molecular dynamics simulations of the NR2A subunit revealed possible binding sites for ethanol near both positions in the M domains. Consistent with this finding, the sum of the molecular volumes of the substituents at the two positions was not correlated with ethanol IC(50) values. Thus, there is a functional interaction between Phe-637 and Met-823 with respect to glutamate potency, desensitization, and ethanol sensitivity, but the two positions do not appear to form a unitary site of alcohol action.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Glutamate-activated currents in NR2A(Phe-637/Met-823) mutant subunits.A, records are currents activated by 1, 10, and 100 μm glutamate in the presence of 50 μm glycine in lifted cells expressing NR1 and wild type NR2A subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and Met-823. One-letter amino acid codes are used.B andC, concentration-response curves for glutamate activation of peak (B) and steady-state (C) current in lifted cells expressing various dual site substitution mutations at NR2A(Phe-637/Met-823). Data are means ± S.E.; error bars not visible were smaller than the size of thesymbols.Curves shown are the best fits to the equation given under “Experimental Procedures.” The fit for the wild type NR2A subunit is shown as adashed line. Plots for single-site mutations are not shown. Values for wild type, NR2A(F637A), and NR2A(F637W) are from Ref. .
FIGURE 2.
FIGURE 2.
Mutations at NR2A(Phe-637/823) can alter glutamate potency and desensitization.A andB, average EC50 values for glutamate activation of peak (A) and steady-state (B) current in lifted cells expressing NR1 and wild type NR2A subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and Met-823. *, EC50 values that are significantly different from that for wild type NR1/NR2A subunits (*,p < 0.05; **,p < 0.01; ANOVA followed by Dunnett's test). Results are means ± S.E. of 5–8 cells.C, average values of maximal steady-state to peak current ratio (Iss/Ip) in lifted cells coexpressing NR1 and wild type NR2A subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and Met-823. Currents were activated by 300 μm glutamate in the presence of 50 μm glycine and 10 μm EDTA. *, values that differed significantly from that for wild type NR1a/NR2A subunits (**,p < 0.01; ANOVA followed by Dunnett's test). Results are means ± S.E. of 5–8 cells.D, graph plots values of maximalIss/Ipversus glutamate log EC50 for steady-state current in the series of mutants. MaximalIss/Ip was significantly correlated with glutamate log EC50 for steady-state (R2 = 0.349,p < 0.05) but not peak (R2 = 0.0515,p > 0.05; results not shown) current. Theline shown is the least-squares fit to the data. Values for wild type, NR2A(F637A), and NR2A(F637W) are from Ref. .
FIGURE 3.
FIGURE 3.
Mutations at NR2A(Phe-637/Met-823) can alter NMDA receptor ethanol sensitivity.A, records are currents activated by 10 μm glutamate and 50 μm glycine and their inhibition by 100 mm ethanol (EtOH) in cells expressing NR1 and wild type NR2A subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and Met-823.B, concentration-response curves for ethanol inhibition of glutamate-activated current in cells expressing various dual site substitution mutations at NR2A(Phe-637/Met-823). Data are means ± S.E. of 5–12 cells; error bars not visible were smaller than the size of thesymbols. Curves shown are the best fits to the equation given under “Experimental Procedures.” The fit for the wild type NR2A subunit is shown as adashed line. Plots for single-site mutations are not shown.C, average IC50 values for ethanol inhibition of glutamate-activated current in cells expressing NR1 and wild type NR2A subunits (F/M) or NR2A subunits containing various mutations at Phe-637 and Met-823. *, EC50 values that are significantly different from that for wild type NR1/NR2A subunits (**,p < 0.01; ANOVA followed by Dunnett's test). Results are means ± S.E. of 5–12 cells. Values for wild type, NR2A(F637A), and NR2A(F637W) are from Ref. ; values for NR2A(M823A), NR2A(M823F), and NR2A(M823W) are from Ref. .
FIGURE 4.
FIGURE 4.
Ethanol sensitivity of NMDA receptors containing NR2A(Phe-637/Met-823) mutant subunits is related to glutamate potency and desensitization.A, the graph plots values of log glutamate EC50 for peak (closed circles) and steady-state (open circles) currentversus log ethanol IC50. Glutamate EC50 was significantly negatively correlated with log ethanol IC50 for steady-state (R2 = 0.501,p < 0.01;dashed line) but not peak (R2 = 0.327,p > 0.05;solid line) current. Thelines shown are the least-squares fits to the data.B, the graph plots values of maximalIss/Ipversus log ethanol IC50. These variables were not significantly correlated when the value for the NR2A(F637W) mutant was included in the analysis (R2 = 0.111;p > 0.05;solid line) but were significantly negatively correlated when this value was excluded from the analysis (R2 = 0.691;p < 0.001;dashed line). Values for wild type, NR2A(F637A), and NR2A(F637W) are from Ref. ; values for NR2A(M823A), NR2A(M823F), and NR2A(M823W) are from Ref. .
FIGURE 5.
FIGURE 5.
Positions 637 and 823 in the NR2A subunit interactively regulate NMDA receptor function and ethanol sensitivity.A andD, the graphs plot EC50 for glutamate activation of peak (A) and steady-state (B) current, maximalIss/Ip (C), and ethanol IC50 (D)versus the substituent at position 823 for the series of mutants at NR2A(Phe-637/Met-823). Although the substituent at 637 did not by itself affect maximalIss/Ip values (p > 0.05; ANOVA), there were highly significant effects of the substituents at 637 and 823 individually on all other measures (p < 0.0001; ANOVA), and highly significant interactions between the substituents at 637 and 823 on all measures (p < 0.0001; ANOVA). Note the departure from parallelism due to the values for subunits containing methionine at position 823.
FIGURE 6.
FIGURE 6.
Combined molecular volume at 637 and 823 in the NR2A subunit is not related to ethanol sensitivity. The graph plots ethanol IC50versus the sum of the molecular volumes (in Å3) of the substituents at positions 637 and 823 for the series of mutants at NR2A(Phe-637/Met-823). There was not a significant linear relation between ethanol sensitivity and molecular volume at the two sites (R2 = 0.0229,p > 0.05).
FIGURE 7.
FIGURE 7.
A molecular model of the NR2A subunit M domains showing putative binding sites for ethanol at positions 637 and 823. A model of the M domains of the NR2A subunit was derived by homology modeling and is depicted as aribbon structure. Following solvation with ethanol, MD simulations were run in which the ethanol was allowed to diffuse away to identify the most probable binding sites. The M2 segment is highlighted inpurple, and Met-825 and Phe-637 are shown inlight blue. Molecules of the ethanol solvent arewhite. Note that two ethanol molecules (light green) remain tightly associated with Phe-637 and Met-823.
See this image and copyright information in PMC

References

    1. Franks, N. P., and Lieb, W. R. (1994) Nature 367 607–614 - PubMed
    1. Peoples, R. W., Li, C., and Weight, F. F. (1996) Annu. Rev. Pharmacol. Toxicol. 36 185–201 - PubMed
    1. Lovinger, D. M., White, G., and Weight, F. F. (1989) Science 243 1721–1724 - PubMed
    1. Lovinger, D. M., White, G., and Weight, F. F. (1990) J. Neurosci. 10 1372–1379 - PMC - PubMed
    1. Hoffman, P. L., Rabe, C. S., Moses, F., and Tabakoff, B. (1989) J. Neurochem. 52 1937–1940 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full text links
Elsevier Science full text link Elsevier Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2026 Movatter.jp